Pyxis Oncology, Inc.(PYXS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PYXS Pyxis Oncology, Inc.

盘后交易 04-14 19:15:56 EDT

1.70

-0.01

-0.58%

盘后1.73

+0.03+1.76%

17:57 EDT

最高1.84	最低1.69	成交量57.65万
今开1.72	昨收1.71	日振幅9.06%
总市值1.07亿	流通市值6,997万	总股本6,283万
成交额100.61万	换手率1.40%	流通股本4,116万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PYXS","market":"US","secType":"STK","nameCN":"Pyxis Oncology, Inc.","latestPrice":1.7,"timestamp":1776196800000,"preClose":1.71,"halted":0,"volume":576460,"hourTrading":{"tag":"盘后","latestPrice":1.73,"preClose":1.7,"latestTime":"17:57 EDT","volume":10926,"amount":18574.8894306,"timestamp":1776203856593,"change":0.03,"changeRate":0.017647,"amplitude":0.017647},"delay":0,"changeRate":-0.005847953216374275,"floatShares":41156263,"shares":62831246,"eps":-1.28,"marketStatus":"盘后交易","change":-0.01,"latestTime":"04-14 19:15:56 EDT","open":1.72,"high":1.84,"low":1.685,"amount":1006076.90305,"amplitude":0.090643,"askPrice":1.86,"askSize":100,"bidPrice":1.54,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.28,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1776211200000},"marketStatusCode":4,"adr":0,"listingDate":1633665600000,"exchange":"NASDAQ","adjPreClose":1.71,"preHourTrading":{"tag":"盘前","latestPrice":1.7,"preClose":1.71,"latestTime":"07:41 EDT","volume":1272,"amount":2173.5143544,"timestamp":1776166869449,"change":-0.01,"changeRate":-0.005848,"amplitude":0.005146},"postHourTrading":{"tag":"盘后","latestPrice":1.73,"preClose":1.7,"latestTime":"17:57 EDT","volume":10926,"amount":18574.8894306,"timestamp":1776203856593,"change":0.03,"changeRate":0.017647,"amplitude":0.017647},"volumeRatio":1.140078,"impliedVol":0.7649,"impliedVolPercentile":0.352},"requestUrl":"/m/hq/s/PYXS/wiki","defaultTab":"wiki","newsList":[{"id":"1107704912","title":"Pyxis Oncology Inc 与Keytruda联合疗法的Micvo 1/2期研究最新数据预计2026年下半年公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1107704912","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107704912?lang=zh_cn&edition=full","pubTime":"2026-03-23 19:13","pubTimestamp":1774264393,"startTime":"0","endTime":"0","summary":"Pyxis Oncology Inc 宣布，其与Keytruda联合进行的Micvo 1/2期临床试验的最新数据，预计将在2026年下半年更新。这一进展备受业界关注，可能为相关治疗领域带来新的突破。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PYXS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132811598","title":"Pyxis Oncology宣布临时CEO任命及领导层交接，聚焦战略重点与项目延续性","url":"https://stock-news.laohu8.com/highlight/detail?id=1132811598","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132811598?lang=zh_cn&edition=full","pubTime":"2026-02-03 19:49","pubTimestamp":1770119377,"startTime":"0","endTime":"0","summary":"波士顿，2026年2月3日——临床阶段生物制药公司Pyxis Oncology, Inc.今日宣布领导层交接计划，旨在持续推进公司战略与临床目标的执行。自公司首次公开募股以来一直担任董事会成员的Thomas Civik被任命为临时首席执行官，即刻生效。通过此次人事调整，Pyxis Oncology将由深度熟悉公司战略及研发项目的资深领导者掌舵。董事会主席John Flavin表示：\"任命Tom为临时CEO是为了确保领导力的稳健过渡与业务连续性。Pyxis Oncology已奠定坚实的科研与临床基础，我们对核心项目的前景保持乐观。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC","BK4022","L","LU0053666078.USD","LU0210528500.USD","BK4231","LU2487616109.SGD","BK4232","BK4139","BK4080","R","BK4107","PYXS","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113961450","title":"Pyxis Oncology任命临时CEO并启动领导层过渡，以强化战略聚焦与项目连续性","url":"https://stock-news.laohu8.com/highlight/detail?id=1113961450","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113961450?lang=zh_cn&edition=full","pubTime":"2026-02-03 19:45","pubTimestamp":1770119115,"startTime":"0","endTime":"0","summary":"生物制药公司Pyxis Oncology, Inc.近日宣布一项重要管理层调整，任命临时首席执行官并启动领导层过渡计划。此次人事变动旨在确保公司战略重点的持续聚焦以及研发项目的稳定推进。\n公司表示，这一过渡性安排将为其核心业务提供有力支撑，同时保持运营效率与决策连贯性。通过优化管理架构，Pyxis Oncology计划进一步巩固其在肿瘤治疗领域的发展态势，为长期价值创造奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYXS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603235815","title":"Forte Biosciences, Inc.盘中异动 早盘股价大涨6.57%报25.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603235815","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603235815?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:34","pubTimestamp":1768228492,"startTime":"0","endTime":"0","summary":"北京时间2026年01月12日22时34分，Forte Biosciences, Inc.股票出现异动，股价大幅上涨6.57%。截至发稿，该股报25.45美元/股，成交量1.1619万股，换手率0.09%，振幅5.11%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.09%。Forte Biosciences, Inc.公司简介：Forte Biosciences Inc 是一家生物制药公司，正在通过临床前试验推进其候选产品 FB-102 的研发，这是一种专有的治疗分子，在移植物抗宿主病，白癜风和斑秃和1型糖尿病等适应症方面具有广泛的自身免疫应用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112223452a4bb1188&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112223452a4bb1188&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FBRX","PYXS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119664554","title":"Pyxis Oncology, Inc.：Micvo的耐受性总体良好，未观察到4级ADC药物负载相关不良事件","url":"https://stock-news.laohu8.com/highlight/detail?id=1119664554","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119664554?lang=zh_cn&edition=full","pubTime":"2025-12-18 20:31","pubTimestamp":1766061073,"startTime":"0","endTime":"0","summary":"Pyxis Oncology, Inc.：Micvo的耐受性总体良好，未观察到4级ADC药物负载相关不良事件。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PYXS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196961385","title":"Pyxis Oncology公布Micvotabart Pelidotin（Micvo）在复发/转移性头颈部鳞状细胞癌中的积极初步I期数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1196961385","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196961385?lang=zh_cn&edition=full","pubTime":"2025-12-18 20:04","pubTimestamp":1766059444,"startTime":"0","endTime":"0","summary":"Pyxis Oncology公布Micvotabart Pelidotin（Micvo）在复发/转移性头颈部鳞状细胞癌中的积极初步I期数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYXS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118303284","title":"Pyxis Oncology第三季度净收入为负2200.3万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1118303284","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118303284?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:26","pubTimestamp":1763569614,"startTime":"0","endTime":"0","summary":"11月3日 - Pyxis Oncology第三季度运营收入为负2346.1万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PYXS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512601711","title":"Pyxis Oncology, Inc.盘中异动 股价大涨5.30%报1.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512601711","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512601711?lang=zh_cn&edition=full","pubTime":"2025-02-19 01:15","pubTimestamp":1739898957,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日01时15分，Pyxis Oncology, Inc.股票出现异动，股价大幅上涨5.30%。截至发稿，该股报1.39美元/股，成交量30.5196万股，换手率0.51%，振幅7.20%。Pyxis Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.51%。Pyxis Oncology, Inc.公司简介：Pyxis Oncology Inc 是一家临床前肿瘤学公司，致力于开发一系列针对难治癌症的新一代治疗药物，改善患者的生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190115579627b2a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190115579627b2a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PYXS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510334593","title":"Pyxis Oncology, Inc.盘中异动 临近午盘股价大跌5.26%报1.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510334593","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510334593?lang=zh_cn&edition=full","pubTime":"2025-02-12 00:34","pubTimestamp":1739291682,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日00时34分，Pyxis Oncology, Inc.股票出现异动，股价快速下挫5.26%。Pyxis Oncology, Inc.股票所在的生物技术行业中，整体跌幅为1.51%。其相关个股中，Omega Therapeutics, Inc.、Lipella Pharmaceuticals Inc.、Dominari Holdings Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2898.52%、1277.81%、427.55%，振幅较大的相关个股有Omega Therapeutics, Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.，振幅分别为78.52%、59.46%、58.60%。Pyxis Oncology, Inc.公司简介：Pyxis Oncology Inc 是一家临床前肿瘤学公司，致力于开发一系列针对难治癌症的新一代治疗药物，改善患者的生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212003442961f5d52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212003442961f5d52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PYXS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510987869","title":"Pyxis Oncology, Inc.盘中异动 早盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510987869","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510987869?lang=zh_cn&edition=full","pubTime":"2025-02-10 23:16","pubTimestamp":1739200592,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日23时16分，Pyxis Oncology, Inc.股票出现异动，股价大幅跳水5.00%。Pyxis Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。Pyxis Oncology, Inc.公司简介：Pyxis Oncology Inc 是一家临床前肿瘤学公司，致力于开发一系列针对难治癌症的新一代治疗药物，改善患者的生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210231632a240aca3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210231632a240aca3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PYXS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505431330","title":"Pyxis Oncology, Inc.盘中异动 早盘快速上涨5.13%报1.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505431330","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505431330?lang=zh_cn&edition=full","pubTime":"2025-01-24 00:19","pubTimestamp":1737649160,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日00时19分，Pyxis Oncology, Inc.股票出现波动，股价快速拉升5.13%。Pyxis Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Exicure, Inc.涨幅较大，Hepion Pharmaceuticals, Inc.、Dogwood Therapeutics, Inc.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为3544.69%、1684.14%、651.17%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Jupiter Neurosciences, Inc.，振幅分别为186.07%、64.29%、55.57%。Pyxis Oncology, Inc.公司简介：Pyxis Oncology Inc 是一家临床前肿瘤学公司，致力于开发一系列针对难治癌症的新一代治疗药物，改善患者的生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124001920960e59a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124001920960e59a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PYXS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504949849","title":"Pyxis Oncology, Inc.盘中异动 下午盘股价大跌5.10%报1.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504949849","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504949849?lang=zh_cn&edition=full","pubTime":"2025-01-17 02:46","pubTimestamp":1737053182,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日02时46分，Pyxis Oncology, Inc.股票出现异动，股价快速下挫5.10%。截至发稿，该股报1.40美元/股，成交量38.7214万股，换手率0.65%，振幅4.85%。Pyxis Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。Pyxis Oncology, Inc.公司简介：Pyxis Oncology Inc 是一家临床前肿瘤学公司，致力于开发一系列针对难治癌症的新一代治疗药物，改善患者的生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117024622abad8695&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117024622abad8695&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PYXS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503685942","title":"Pyxis Oncology, Inc.盘中异动 下午盘股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503685942","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503685942?lang=zh_cn&edition=full","pubTime":"2025-01-15 03:50","pubTimestamp":1736884253,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日03时50分，Pyxis Oncology, Inc.股票出现波动，股价快速跳水5.23%。Pyxis Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.76%。Pyxis Oncology, Inc.公司简介：Pyxis Oncology Inc 是一家临床前肿瘤学公司，致力于开发一系列针对难治癌症的新一代治疗药物，改善患者的生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115035053a221fa7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115035053a221fa7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PYXS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502898376","title":"Pyxis Oncology, Inc.盘中异动 股价大跌5.59%报1.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502898376","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502898376?lang=zh_cn&edition=full","pubTime":"2025-01-10 23:09","pubTimestamp":1736521792,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日23时09分，Pyxis Oncology, Inc.股票出现波动，股价快速下挫5.59%。截至发稿，该股报1.52美元/股，成交量18.5536万股，换手率0.31%，振幅3.73%。Pyxis Oncology, Inc.股票所在的生物技术行业中，整体跌幅为1.33%。Pyxis Oncology, Inc.公司简介：Pyxis Oncology Inc 是一家临床前肿瘤学公司，致力于开发一系列针对难治癌症的新一代治疗药物，改善患者的生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501102309529861f25d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501102309529861f25d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PYXS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501745707","title":"Pyxis Oncology, Inc.盘中异动 早盘大幅下跌5.12%报1.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501745707","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501745707?lang=zh_cn&edition=full","pubTime":"2025-01-08 22:44","pubTimestamp":1736347460,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日22时44分，Pyxis Oncology, Inc.股票出现异动，股价快速跳水5.12%。截至发稿，该股报1.65美元/股，成交量6.8903万股，换手率0.12%，振幅3.45%。Pyxis Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Pyxis Oncology, Inc.公司简介：Pyxis Oncology Inc 是一家临床前肿瘤学公司，致力于开发一系列针对难治癌症的新一代治疗药物，改善患者的生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010822442195fd0174&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010822442195fd0174&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PYXS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500978898","title":"Pyxis Oncology, Inc.盘中异动 急速上涨5.13%报1.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500978898","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500978898?lang=zh_cn&edition=full","pubTime":"2025-01-02 22:32","pubTimestamp":1735828365,"startTime":"0","endTime":"0","summary":"北京时间2025年01月02日22时32分，Pyxis Oncology, Inc.股票出现异动，股价大幅拉升5.13%。截至发稿，该股报1.64美元/股，成交量3.6112万股，换手率0.06%，振幅2.56%。Pyxis Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。Pyxis Oncology, Inc.公司简介：Pyxis Oncology Inc 是一家临床前肿瘤学公司，致力于开发一系列针对难治癌症的新一代治疗药物，改善患者的生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102223245ab9bf68d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102223245ab9bf68d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PYXS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2493087055","title":"Pyxis Oncology, Inc.盘中异动 急速下挫5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493087055","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493087055?lang=zh_cn&edition=full","pubTime":"2024-12-24 22:48","pubTimestamp":1735051685,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日22时48分，Pyxis Oncology, Inc.股票出现波动，股价大幅下挫5.39%。Pyxis Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.57%。Pyxis Oncology, Inc.公司简介：Pyxis Oncology Inc 是一家临床前肿瘤学公司，致力于开发一系列针对难治癌症的新一代治疗药物，改善患者的生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122422480595eb2832&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122422480595eb2832&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PYXS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2493761661","title":"Pyxis Oncology, Inc.盘中异动 早盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493761661","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493761661?lang=zh_cn&edition=full","pubTime":"2024-12-23 23:04","pubTimestamp":1734966287,"startTime":"0","endTime":"0","summary":"北京时间2024年12月23日23时04分，Pyxis Oncology, Inc.股票出现波动，股价大幅下跌5.03%。Pyxis Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。其相关个股中，Traws Pharma, Inc.、Rapt Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Phio Pharmaceuticals Corp.、Gt Biopharma, Inc.、Traws Pharma, Inc.较为活跃，换手率分别为758.86%、497.83%、496.17%，振幅较大的相关个股有Traws Pharma, Inc.、Rapt Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为116.73%、104.19%、57.92%。Pyxis Oncology, Inc.公司简介：Pyxis Oncology Inc 是一家临床前肿瘤学公司，致力于开发一系列针对难治癌症的新一代治疗药物，改善患者的生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122323044795eadc89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122323044795eadc89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PYXS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2493475362","title":"Pyxis Oncology, Inc.盘中异动 下午盘急速上涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493475362","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493475362?lang=zh_cn&edition=full","pubTime":"2024-12-21 03:28","pubTimestamp":1734722930,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日03时28分，Pyxis Oncology, Inc.股票出现波动，股价快速上涨5.19%。Pyxis Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。Pyxis Oncology, Inc.公司简介：Pyxis Oncology Inc 是一家临床前肿瘤学公司，致力于开发一系列针对难治癌症的新一代治疗药物，改善患者的生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221032850a1fea087&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221032850a1fea087&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PYXS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492311172","title":"Pyxis Oncology, Inc.盘中异动 股价大涨7.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492311172","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492311172?lang=zh_cn&edition=full","pubTime":"2024-12-19 22:31","pubTimestamp":1734618679,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日22时31分，Pyxis Oncology, Inc.股票出现异动，股价快速上涨7.30%。Pyxis Oncology, Inc.股票所在的生物技术行业中，整体跌幅为2.72%。其相关个股中，Bio-Path Holdings, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Bio-Path Holdings, Inc.、Phio Pharmaceuticals Corp.、Elevai Labs, Inc.较为活跃，换手率分别为1840.87%、404.26%、304.93%，振幅较大的相关个股有Bio-Path Holdings, Inc.、Genprex, Inc.、Oragenics Inc.，振幅分别为19.43%、10.86%、9.29%。Pyxis Oncology, Inc.公司简介：Pyxis Oncology Inc 是一家临床前肿瘤学公司，致力于开发一系列针对难治癌症的新一代治疗药物，改善患者的生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219223122a1fb5880&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219223122a1fb5880&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PYXS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pyxisoncology.com","stockEarnings":[{"period":"1week","weight":0.1793},{"period":"1month","weight":0.1104},{"period":"3month","weight":-0.0904},{"period":"6month","weight":-0.5328},{"period":"1year","weight":0.7837},{"period":"ytd","weight":0.487}],"compareEarnings":[{"period":"1week","weight":0.0412},{"period":"1month","weight":0.036},{"period":"3month","weight":-0.0111},{"period":"6month","weight":0.0315},{"period":"1year","weight":0.285},{"period":"ytd","weight":0.0061}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Pyxis Oncology, Inc.于2018年6月11日在特拉华州注册成立。该公司是一家临床阶段的肿瘤学公司，推进专注于解决实体瘤患者未满足的医疗需求的发展战略，并立即关注头颈部鳞状细胞癌（HNSCC）。","yearOnYearQuotes":[{"month":1,"riseRate":0.8,"avgChangeRate":0.283554},{"month":2,"riseRate":0.6,"avgChangeRate":0.106698},{"month":3,"riseRate":0.2,"avgChangeRate":-0.016511},{"month":4,"riseRate":0.6,"avgChangeRate":-0.063901},{"month":5,"riseRate":0.75,"avgChangeRate":0.010034},{"month":6,"riseRate":0,"avgChangeRate":-0.111822},{"month":7,"riseRate":1,"avgChangeRate":0.080932},{"month":8,"riseRate":0.25,"avgChangeRate":-0.016997},{"month":9,"riseRate":0.25,"avgChangeRate":0.094044},{"month":10,"riseRate":0.25,"avgChangeRate":0.090516},{"month":11,"riseRate":0.2,"avgChangeRate":-0.058552},{"month":12,"riseRate":0.2,"avgChangeRate":-0.217409}],"exchange":"NASDAQ","name":"Pyxis Oncology, Inc.","nameEN":"Pyxis Oncology, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pyxis Oncology, Inc.(PYXS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Pyxis Oncology, Inc.(PYXS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Pyxis Oncology, Inc.,PYXS,Pyxis Oncology, Inc.股票,Pyxis Oncology, Inc.股票老虎,Pyxis Oncology, Inc.股票老虎国际,Pyxis Oncology, Inc.行情,Pyxis Oncology, Inc.股票行情,Pyxis Oncology, Inc.股价,Pyxis Oncology, Inc.股市,Pyxis Oncology, Inc.股票价格,Pyxis Oncology, Inc.股票交易,Pyxis Oncology, Inc.股票购买,Pyxis Oncology, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pyxis Oncology, Inc.(PYXS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Pyxis Oncology, Inc.(PYXS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}